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Abstract
Background: The proteins from the UBA-UBX family interact with ubiquitylated proteins via their UBA domain and
with p97 via their UBX domain, thereby acting as substrate-binding adaptors for the p97 ATPase. In particular,
human UBXN7 (also known as UBXD7) mediates p97 interaction with the transcription factor HIF1a that is actively
ubiquitylated in normoxic cells by a CUL2-based E3 ligase, CRL2. Mass spectrometry analysis of UBA-UBX protein
immunoprecipitates showed that they interact with a multitude of E3 ubiquitin-ligases. Conspicuously, UBXN7 was
most proficient in interacting with cullin-RING ligase subunits. We therefore set out to determine whether UBXN7
interaction with cullins was direct or mediated by its ubiquitylated targets bound to the UBA domain.
Results: We show that UBXN7 interaction with cullins is independent of ubiquitin- and substrate-binding. Instead,
it relies on the UIM motif in UBXN7 that directly engages the NEDD8 modification on cullins. To understand the
functional consequences of UBXN7 interaction with neddylated cullins, we focused on HIF1a, a CUL2 substrate
that uses UBXD7/p97 as a ubiquitin-receptor on its way to proteasome-mediated degradation. We find that UBXN7
over-expression converts CUL2 to its neddylated form and causes the accumulation of non-ubiquitylated HIF1a.
Both of these effects are strictly UIM-dependent and occur only when UBXN7 contains an intact UIM motif. We
also show that HIF1a carrying long ubiquitin-chains can recruit alternative ubiquitin-receptors, lacking p97’s ATP-
dependent segregase activity.
Conclusions: Our study shows that independently of its function as a ubiquitin-binding adaptor for p97, UBXN7
directly interacts with neddylated cullins and causes the accumulation of the CUL2 substrate HIF1a. We propose
that by sequestering CUL2 in its neddylated form, UBXN7 negatively regulates the ubiquitin-ligase activity of CRL2
and this might prevent recruitment of ubiquitin-receptors other than p97 to nuclear HIF1a.
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Background
Proteins destined for proteasome-mediated degradation
are labeled with ubiquitin chains through the action of
an enzymatic cascade consisting of a ubiquitin-activating
enzyme (E1), a ubiquitin-conjugating enzyme (E2), and
a ubiquitin-ligase (E3) [1]. Downstream of ubiquityla-
tion, ubiquitin-receptors recognize the poly-ubiquity-
lated proteins and facilitate their degradation by the
proteasome [2]. Some ubiquitin-receptors, such as
PSMD4 (known as Rpn10 in yeast) and RPN13, are
intrinsic to the regulatory particle of the proteasome
[3,4]. Others, such as those from the RAD23 or ubiqui-
lin families, shuttle on and off the proteasome [5]. In
addition to the single subunit receptors mentioned
above, a distinct class of ubiquitin-receptors endowed
with ATPase activity has at its core p97 hexamers. It
has been proposed that p97 functions as a ‘segregase’ by
converting the ATP-derived energy into mechanical
force [6-8]. Indeed, p97 complexes can separate their
substrates from cellular structures, such as the endoplas-
mic-reticulum membrane [9], or from protein partners
[7,10]. The p97 protein itself has little affinity for
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binding adaptors to function as a ubiquitin-receptor.
Such adaptors include the NPL4/UFD1 dimer [11,12]
and the UBA-UBX proteins [13]. The latter employ
their UBX domain to interact with the N-terminus of
p97 and the UBA (ubiquitin-associated) domain to bind
ubiquitylated proteins [14]. Humans express five UBA-
UBX proteins: UBXN7, FAF1, FAF2, UBXN1, and p47.
A striking observation from the mass spectrometry ana-
lysis of UBA-UBX protein immunoprecipitates is their
ability to interact with a large number of E3 ubiquitin-
ligases [15]. These include components of cullin-RING
E3 ligase (CRL) complexes and also single subunit
RING- and HECT-domain E3s.
Similar to ubiquitin, the ubiquitin-like (UBL) protein
NEDD8 is attached to its substrates by specific E1, E2
and E3 enzymes. To date, cullins represent the major
class of proteins that are targets for neddylation [16].
The NEDD8 E3 activity in this case is provided by the
dual action of DCN1 [17-19] and the RING subunit of
the CRL complex [20-22]. It has been known for over a
decade that cullin-neddylation is essential for the E3
activity of CRL complexes [23]. Recent structural and
biochemical studies elucidated the complex molecular
mechanism underlying CRL activation by the NEDD8
modification. Neddylation induces a major conforma-
tional change in the cullin that essentially allows the
RING domain of RBX1 to spring free from the cullin. It
is this increased flexibility of the RING-domain that ulti-
mately translates into superior ubiquitin-ligase activity
of CRLs [24,25].
We have previously identified HIF1a as a novel sub-
strate of p97, with the UBA-UBX protein UBXN7 ser-
ving as the substrate-binding adaptor [15]. HIF1a
heterodimerizes with HIF1b to form the HIF1 transcrip-
tion factor that is essential during hypoxia for triggering
t h ee x p r e s s i o no fs p e c i f i cp r o teins required to counter-
act the hypoxic stress [26]. HIF1a is continuously
expressed during normoxia and is actively targeted for
ubiquitin-mediated degradation through the action of a
CUL2-based CRL complex (CRL2). Within CRL2, CUL2
acts as a scaffold to which the RING subunit (RBX1)
and the elongin B/elongin C dimer bind. VHL docks on
elongin C and directly interacts with HIF1a [27], acting
as a substrate-binding adaptor for the CRL2 complex
(Figure 1A). Consistent with p97 having a positive role
in HIF1a degradation, HIF1a accumulates upon p97
depletion by siRNA. Paradoxically, UBXN7 depletion
results in reduced levels of HIF1a,i n d i c a t i n gt h a t
UBXN7 involvement in HIF1a degradation is more
complex than anticipated [15].
Here we show that UBXN7 interaction with cullins is
not mediated by its ubiquitylated substrates, but involves
the direct docking of the UIM motif in UBXN7 onto the
neddylated cullins. UBXN7 over-expression causes non-
ubiquitylated HIF1a to accumulate in a manner that is
dependent on an intact UIM motif in UBXD7. Our data
suggest that UBXN7 may act as a negative regulator of
CRL2 and this would favor subsequent recruitment of
p97.
Results
Active ubiquitylation is not necessary for UBXN7
interaction with CUL2
Among human UBA-UBX proteins, UBXN7 is the most
proficient in interacting with CRL subunits. Indeed, its
ability to interact with CUL2 greatly outshines other
UBA-UBX proteins [15]. We therefore set out to further
explore UBXN7 interaction with CRL2. Our initial
assumption was that the interaction of UBA-UBX pro-
teins with E3 ubiquitin-ligases was indirect, mediated by
their ubiquitylated substrates. To test this hypothesis we
used the A31N-ts20 cells, which are mouse embryo
fibroblasts thermosensitive for the ubiquitin-E1 [28].
When these cells are grown at the non-permissive tem-
perature, the initial step in the protein-ubiquitylation
cascade is blocked leading to a dramatic reduction in
the levels of ubiquitylated proteins compared to control
cells grown at 35°C (Figure 1B). As an added proof that
the ubiquitylation pathway was defective, we observed
HIF1a accumulation in the cells grown at 39°C.
Although ubiquitin-binding to Flag-UBXN7 was drasti-
cally reduced, UBXN7 interaction with CUL2 was unaf-
fected (Figure 1B).
UBXN7 stably interacts with the core CRL2 complex
Next we examined UBXN7 interaction with other com-
ponents of the CRL2 complex. Flag-UBXN7 effectively
co-immunoprecipitated CUL2, elongin C and RBX1,
which constitute the core CRL2 complex. In contrast,
UBXN7 interaction with VHL and HIF1a could only be
observed upon brief inhibition of the proteasome with
MG132 (Figure 1C). Similar results were obtained when
endogenous UBXN7 was immunoprecipitated using spe-
cific antibodies (Figure 1D).
The data presented thus far indicated that UBXN7
binding to CUL2 was not mediated by its interaction
with ubiquitylated-proteins that are CRL2 substrates.
This raised the interesting hypothesis that UBXN7
might interact directly with the CRL2 core complex,
irrespective of whether it is charged with a substrate
(Figure 1A).
Cullin-neddylation is required for the interaction with
UBXN7
We observed that UBXN7 interacted preferentially with
the neddylated form of CUL2, which was largely depleted
from the extracts after Flag-UBXN7 immunoprecipitation
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Page 2 of 15(Figure 2A, compare lanes 3 and 4). We also noticed that
Flag-UBXN7 over-expression causes an up-shift of CUL2
to a slower migrating form (Figure 2B). To confirm that
this is indeed neddylated-CUL2, we used a chemical inhi-
bitor of the NEDD8-E1, MLN4924 [29]. MLN4924 abol-
ished cullin-neddylation and also the CUL2 up-shift
caused by UBXN7 over-expression (Figure 2B). To inves-
tigate the possibility that cullin-neddylation is required
for the interaction with UBXN7, we created two
neddylation-defective CUL2 mutants, K689R and K719R.
Lys689 is the site of NEDD8-conjugation in human
CUL2 and mutating this residue to arginine abolishes
neddylation [30]. Lys719 is a conserved residue among
cullins and its equivalent in yeast Cdc53 is part of the
interaction surface with Dcn1 [17] (Figure 2C). CUL2-
neddylation was largely defective in the K719R mutant
(Figure 2D), presumably due to its inability to interact
with the DCN1 component of the NEDD8-E3. We
A
CUL2
EloC
EloB RBX1
VHL
HIF1α
N
E
D
D
8
Ub
Ub
Ub
Ub UBA UBX
?
D
UBXN7 IPs
-- ++ MG132
Mock
UBXN7
CUL2
Elongin C
RBX1
VHL
CORE
CRL2
SUBUNITS
Input extracts
- ++
250
150
100
-
250
150
100
HIF1α
-(Ub)n
HIF1α
HIF1α
WB
UBXN7
Flag-UBXN7 IPs
CUL2
Flag-UBXN7
39 oC 35
Input B
Anti-Flag IPs
-- + +
Flag-UBXN7
MG132
Flag-UBXN7 - - + +
HIF1α-(Ub)n
HIF1α
CUL2
HIF1α
WB
Input extracts
-- + + MG132
Flag-UBXN7 - - + +
250
150
100
Elongin C
RBX1
VHL
CORE
CRL2
SUBUNITS
HIF1α
250
150
100
250
150
100
39 oC 35
Ubi
250
150
100
250
150
100
HIF1α
250
150
100
C
Ubi
WB
HIF1α
WB
Figure 1 Ubiquitin- and substrate-binding to UBXN7 do not correlate with CUL2 binding.( A) Illustration of the CRL2 ubiquitin-ligase
bound to its substrate HIF1a. The core subunits of CRL2 are highlighted in blue. The UBA-UBX protein UBXN7 interacts with ubiquitylated HIF1a
via its UBA domain. (B) CUL2 interaction with UBXN7 is independent of ubiquitin-binding. Flag-UBXN7 was immunoprecipitated from cells
thermo-sensitive for the ubiquitin-E1. When these cells were grown at the restrictive temperature for 20 hours, there was a marked reduction in
protein ubiquitylation (right panel). CUL2-binding to UBXN7 was not affected by the reduced ubiquitin-binding observed under these conditions
(left panel). (C) Flag-UBXN7 stably interacts with the core subunits of the CRL2 complex. Flag-UBXN7 was immunoprecipitated from HeLa cells
treated or not with 10 μM MG132 for two hours. Flag-UBXN7 stably interacted with CUL2, elongin C and RBX1. The interaction with HIF1a and
VHL could only be detected upon proteasome inhibition (left panel). (D) Endogenous UBXN7 stably interacts with the core subunits of the CRL2
complex. As in (C), but endogenous UBXN7 was immunoprecipitated from HeLa cells using specific antibodies crosslinked to protein A-beads.
(B-D) The indicated proteins were detected using specific antibodies in the immunoprecipitates (left) and the input cell extracts (right).
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Page 3 of 15attempted to test whether this mutant was defective in
binding the human DCN1-like protein, but DCNL1 was
undetectable even in wild-type Flag-CUL2 immunopreci-
pitates. None of the above mutations affected CUL2
interaction with RBX1 (Figure 2D). Strikingly, there was a
precise correlation between CUL2-neddylation and its
ability to interact with endogenous UBXN7. UBXN7
binding was completely abolished in the K689R mutant
and strongly reduced in the K719R mutant (Figure 2D).
Thus, neddylation was required for CUL2 interaction
with UBXN7. This is a common feature among cullins,
because MLN4924 treatment prevented not only UBXN7
interaction with CUL2, but also with CUL1, CUL3 and
CUL4A (Figure 2E). The defect in cullin-binding caused
by MLN4924 treatment could not be rescued by simulta-
neous treatment with the proteasome inhibitor MG132
(Figure 2E). In contrast, MLN4924 treatment did not
affect UBXN7 interaction with ubiquitylated-proteins or
with p97 (Figure 2F).
The UIM motif of UBXN7 is required to engage the
NEDD8 modification on cullins
Because UBXN7 preferentially interacted with neddy-
lated-CUL2 and cullin-neddylation was a prerequisite
for the interaction to occur, we became intrigued with
the possibility that the NEDD8 modification on cullins
might be directly involved in recruiting UBXN7. We
therefore turned our attention to UBXN7 and the var-
ious domains that are part of its structure. At the N-ter-
minus of UBXN7 there is a UBA domain, followed by a
UAS domain of unknown function, a UIM motif and a
UBX domain at the C-terminus (Figure 3A). To investi-
gate whether any of these domains was required for
UBXN7 interaction with CUL2, we compared the ubi-
quitin- and CUL2-binding capability of several UBXN7
variants, including wild-type, a point mutant in the UBX
domain (P459G), and truncation mutants lacking either
the UBA, the UAS, the UIM or the UBX domain
(Figures 3B and 3C). The deletion of the UAS domain
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Figure 2 UBXN7 exclusively interacts with neddylated cullins in cell extracts.( A) UBXN7 preferentially interacts with slower-migrating,
neddylated CUL2. Input cell extracts and the supernatants after Flag-UBXN7 immunoprecipitation were compared. (B) Flag-UBXN7 over-
expression causes an up-shift of CUL2 to its neddylated form. This effect was abolished when the cells were grown in the presence of the
NEDD8-E1 inhibitor MLN4924 for two hours. (C) Alignment of human CUL2 with the yeast cullin Cdc53. The conserved neddylation site (K689)
and a more C-terminal Lys residue involved in the interaction with Dcn1 (K719) are highlighted in red. (D) Neddylation-defective CUL2 variants
are similarly defective in interacting with endogenous UBXN7. Wild-type or mutant Flag-CUL2 was immunoprecipitated from HeLa cells treated
or not with 10 μM MG132 for two hours. (E) MLN4924 treatment abolishes UBXN7 interaction with several endogenous cullins. (F) MLN4924
treatment has no effect on UBXN7 interaction with ubiquitylated-proteins or with p97. (E, F) Flag-UBXN7 was immunoprecipitated from HeLa
cells treated with MG132, MLN4924, or a combination of the two. The indicated proteins were detected using specific antibodies.
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Figure 3 An intact UIM motif is necessary for UBXN7 interaction with neddylated-CUL2.( A) Schematic representation of human UBXN7
highlighting its various domains. (B-D) Wild-type or mutant Flag-UBXN7 was immunoprecipitated from HeLa cells. The indicated proteins were
detected using specific antibodies in the immunoprecipitates (left) and the input cell extracts (right). (B) Either UBA- or UIM-deletion caused a
reduction in ubiquitin-binding to UBXN7. UBX-deletion or a point mutation in this domain (P459G) abolished p97-binding and severely impaired
the interaction with ubiquitylated proteins (left panel). (C) UIM-deletion, but not other mutations, caused a strong reduction in CUL2-binding to
UBXN7 (left panel) and abolished the CUL2 up-shift caused by UBXN7 over-expression (right panel). (D) Point mutations within the UIM motif at
Ser297 caused a defect in CUL2-binding to UBXN7 similar to UIM-deletion. p97-binding was not affected by these mutations (left panel).
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Page 5 of 15had largely no effect on UBXN7 interaction with ubiqui-
tin, p97 or CUL2. Both ΔUBA and ΔUIM truncation
mutants were partially defective in ubiquitin-binding
(Figure 3B, compare lanes 2, 4 with 1). Interestingly,
while ΔUBA had wild-type capability to bind CUL2 (Fig-
ure 3C,compare lanes 1 and 2), the ΔUIM truncation
caused a pronounced reduction in CUL2-binding (Fig-
ure 3C, compare lanes 1 and 4). These results suggested
that the UIM motif was required for CUL2-binding,
while the UBA domain was not.
As expected, both UBX-deletion and a point mutation
in this domain (P459G) abolished p97 binding (Figure
3B). Surprisingly, these mutations also affected ubiqui-
tin-binding, suggesting that they have a broad effect on
UBXN7 function, possibly by altering the overall struc-
ture of the protein. Although UBX mutants were
severely defective in p97- and ubiquitin-binding, they
largely retained their ability to interact with CUL2 (Fig-
ure 3C), supporting the notion that UBXN7 binding to
CUL2 is independent of its binding to p97 or ubiquity-
lated-proteins.
Consistent with the reduced binding of UBXN7 ΔUIM
to CUL2, over-expression of this mutant failed to cause
an up-shift of CUL2 to the neddylated form (Figure 3C,
compare lanes 8 and 11). In effect, CUL2 migration in
cells expressing UBXN7 ΔUIM was similar to untrans-
fected cells (Figure 3C, lanes 11 and 14).
Various residues within the UIM motif are essential
for its interaction with ubiquitin [31,32]. We found that
mutating Ser297 to either Ala or His causes a defect in
binding neddylated-CUL2 similar to UIM deletion (Fig-
ure 3D, compare lanes 4, 5 with 3). We therefore con-
clude that both UIM-deletion and point mutations in
this motif negatively affect UBXN7 interaction with ned-
dylated-cullin.
To further substantiate the ability of the UIM motif
in UBXN7 to interact with NEDD8 rather than ubiqui-
tin we performed in vitro binding assays to NEDD8- or
ubiquitin-agarose. Wild-type UBXN7 was pulled-down
efficiently with both types of beads (Figure 4A). Dele-
tion of the UIM motif caused a marked reduction in
NEDD8-binding and had no effect on ubiquitin-bind-
ing, while UBA-deletion abolished ubiquitin-binding
and caused some reduction in NEDD8-binding as well.
T h e s ed a t as t r o n g l ys u p p o r tt h en o t i o nt h a tt h eU I M
motif of UBXN7 is specialized in recognizing NEDD8
and can directly engage the NEDD8 modification on
cullins.
UBXN7 interacts with cullin-RING complexes in vitro
To check whether UBXN7 could interact with cullin
complexes in vitro, we used anti-Flag beads to immuno-
precipitate Flag-tagged UBXN7 incubated with either
unmodified CUL2 or CUL2 that was in vitro neddylated.
Only a fraction of CUL2 became neddylated, because
RBX1 was present in substoichiometric amounts in our
CUL2 preparation. We found that wild-type UBXN7
could interact efficiently with CUL2 irrespective of its
neddylation status (Figure 4B). A UBXN7 variant lacking
the UIM motif was equally proficient in interacting with
both forms of CUL2 (Figure 4C). Under these condi-
tions UBXN7 interaction with CUL2 does not appear to
depend strictly on either UIM or NEDD8. To eliminate
potential binding sites in the N-terminal half of the cul-
lin, we then used bacterially expressed GST-RBX1 in
complex with the C-terminal fragment of CUL1 (amino
acids 324-776) [33]. The CUL1/RBX1 complex immobi-
lized on glutathione-beads was either neddylated or
exposed to a mock neddylation-mix without NEDD8.
All UBXN7 variants tested interacted to some degree
with the non-neddylated CUL1 fragment (Figure 4D).
Upon CUL1-neddylation, the interaction with wild-type
UBXN7 and also with the ΔUBA mutant was enhanced,
while the interaction with the ΔUIM mutant remained
unaffected (Figure 4D). We therefore established that
UBXN7 can directly interact with cullins in vitro and
confirmed that the UIM-NEDD8 contact has a contribu-
tion, albeit not as important as observed using cell
extracts.
UBXN7 over-expression causes HIF1a accumulation in a
UIM-dependent manner
Because various UBXN7 mutants had altered ability to
interact with ubiquitylated-proteins or with CUL2, we
checked whether their expression in the cell might have
any consequence on the levels of HIF1a,w h i c hi sa
CRL2 substrate [27] and also interacts with UBXN7
[15]. Over-expression of wild-type UBXN7 caused a sig-
nificant accumulation of HIF1a in its non-ubiquitylated
form (Figure 5A, compare lanes 1 and 2). Most impor-
tantly, this effect was dependent on the UIM motif, as
HIF1a levels in cells over-expressing a UIM-deleted ver-
sion of UBXN7 were similar to untransfected cells (Fig-
ure 5A, lanes 1 and 5). In contrast, the levels of the
CRL2 subunits CUL2, VHL, elongin C and RBX1
remained unaffected (Figure 5A). UBXN7 is unique in
its ability to cause UIM-dependent accumulation of
HIF1a, as over-expression of another UIM-containing
ubiquitin-receptor, the proteasome subunit PSMD4, had
no effect on HIF1a levels (Figure 5B).
To facilitate HIF1a detection, for the experiments
shown in Figures 5A and 5B, the cells were subjected to
brief inhibition of the proteasome activity prior to cell
lysis. However, UIM-dependent accumulation of HIF1a
upon UBXN7 over-expression could also be observed in
the absence of MG132 treatment (Figures 5C and 5D,
right panels). Point mutations at Ser297 in the UIM
motif that negatively affect CUL2-binding (Figure 3D)
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Page 6 of 15also abolished HIF1a accumulation, similar to UIM-
deletion (Figure 5C, right panel).
Previous reports identified a phosphorylation site
within the UIM motif of human UBXN7 at Ser288
[34,35]. We therefore created a phosphorylation-defec-
tive (S288A) and a phosphorylation-mimicking mutant
(S288D) of that residue to verify whether phosphoryla-
tion of Ser288 might regulate UIM function. Both
mutants behaved similar to wild-type with respect to
CUL2- and HIF1a-binding (Figure 5D). They also
caused HIF1a accumulation, much like wild-type
UBXN7 (Figure 5D, right panel). Therefore, phosphory-
lation at Ser288 does not appear to be critical for UIM
function.
Interestingly, the defect in CUL2-binding observed for
the UIM-defective mutants correlated with a complete
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Figure 4 UBXN7 directly interacts with NEDD8 and cullins in vitro.( A) The UIM motif of UBXN7 directly recognizes NEDD8. The deletion of
the UIM motif exclusively reduces UBXN7 binding to NEDD8 while deletion of the UBA domain abolishes the interaction with ubiquitin. NEDD8
or ubiquitin-agarose beads were incubated with the indicated recombinant variants of UBXN7. (B) Wild-type UBXN7 efficiently pulls-down CUL2
irrespective of its modification status (left panel). Bacterially expressed Flag-UBXN7 was pre-incubated with full-length CUL2 either unmodifiedo r
partially neddylated and then immunoprecipitated using anti-Flag beads. (C) The in vitro interaction of UBXN7 with full-length CUL2 is not
affected by UIM deletion. Wild-type or UIM-deleted Flag-UBXN7 was incubated with a mixture of neddylated and non-neddylated CUL2 and
then immunoprecipitated as in (B). (D) Cullin-neddylation increases the binding of full-length and UBA-deleted UBXN7, but not of the UIM-
deleted mutant. GSH-beads coated with either non-neddylated or a mixture of neddylated and non-neddylated CUL1(342-776)/GST-RBX1 were
incubated with the indicated UBXN7 variants. Naked GSH-beads were used as a control. The Flag western blot in the right panel shows similar
input levels for the three UBXN7 variants.
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Figure 5 UBXN7 over-expression causes HIF1a accumulation in a UIM-dependent manner.( A) Non-ubiquitylated HIF1a accumulates in
cells over-expressing wild-type Flag-UBXN7, but not in cells expressing a UIM-deleted version. 10 μM MG132 was added two hours prior to cell
lysis to facilitate HIF1a detection. UBXN7 over-expression had no effect on CRL2 subunit levels. (B) Over-expression of another UIM-containing
protein, PSMD4, does not alter HIF1a levels. (C, D) UIM-dependent accumulation of non-ubiquitylated HIF1a upon UBXN7 over-expression is also
observed in the absence of proteasome inhibition (right panels). Wild-type UBXN7 interacted with HIF1a at various degrees of ubiquitylation,
while UIM-defective UBXN7 (upon UIM deletion or point mutation at Ser297) only interacted with slow-migrating, poly-ubiquitylated HIF1a (left
panels). The corresponding Flag, CUL2 and p97 western blots for the experiment in (C) are shown in figure 3D. (D) UBXN7 mutated at Ser288
within the UIM motif binds CUL2 (left panel) and causes HIF1a accumulation (right panel), similar to the wild-type protein. The indicated
proteins were detected using specific antibodies.
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Page 8 of 15loss of binding to non- or oligo-ubiquitylated HIF1a
(Figure 5C). Nonetheless, these mutants retained the
ability to interact with poly-ubiquitylated HIF1a (that is,
the slowest migrating forms of HIF1a), presumably via
the UBA domain.
Long ubiquitin-chains on HIF1a cause reduced ubiquitin-
receptor selectivity
We previously observed that HIF1a carrying long ubi-
quitin-chains can interact, albeit inefficiently, with UBA-
UBX proteins other than UBXN7 [15]. Consistent with
it being pre-docked on the CRL2 complex, UBXN7
interacted with HIF1a at various degrees of ubiquityla-
tion, from non- or oligo-ubiquitylated to poly-ubiquity-
lated (Figure 6A). In contrast, another UBA-UAS-UBX
protein, FAF1, only interacted with slower migrating
HIF1a (Figure 6A), similar to UBXN7 lacking the UIM
motif (Figure 5D).
Flag-UBXN7 was found exclusively in the nuclei of
HeLa cells (Figure 6B). RAD23B, another UBA-domain
ubiquitin-receptor also localizes to the nuclear compart-
ment [36,37] and this prompted us to check whether it
may also interact with HIF1a. Like FAF1, RAD23B was
able to co-immunoprecipitate HIF1a carrying longer
ubiquitin-chains (Figure 6C). Hence, as the ubiquitin-
chains get longer, the substrate appears less selective in
its interaction with ubiquitin-receptors. Our observa-
tions suggest that UBXN7 targets mainly the nuclear
pool of HIF1a and it may compete with RAD23B for
ubiquitylated-HIF1a in the nucleus.
Discussion
UBXN7 interaction with cullins requires neddylation and
is independent of the ubiquitylated substrate
Multiple lines of evidence indicate that ubiquitin/sub-
strate-binding and cullin-binding to UBXN7 are two
independent events: (1) inhibition of the ubiquitin-E1
strongly reduces ubiquitin-binding, but it has no effect
on CUL2-binding to UBXN7; (2) UBXN7 interaction
with HIF1a/VHL is transient and strongly enhanced
upon proteasome inhibition while UBXN7 interaction
with the core CRL2 complex is stable; (3) UBA-domain
deletion reduces ubiquitin-binding to UBXN7, but it
does not affect the interaction with CUL2.
Furthermore, several observations support the notion
that neddylation is necessary for UBXN7 interaction
with cullins: (1) CUL2 mutants defective to varying
degrees in getting neddylated are similarly defective in
UBXN7 binding; (2) chemical inhibition of the NEDD8-
E1 abolishes the interaction of UBXN7 with multiple
cullins; (3) in vitro neddylation of a CUL1-fragment sti-
mulates its interaction with bacterially-expressed
UBXN7, in a UIM-dependent manner. In vitro,U B X N 7
can interact with non-neddylated cullins suggesting that
UIM-NEDD8 may not be the only link between UBXN7
and CRLs. As we used simplified CRLs containing only
the cullin and RBX1, these other binding determinants
might be particularly accessible, thereby relinquishing
the strict requirement for neddylation that we observed
for the native form of CUL2 present in cell extracts.
UBXN7, one domain for each interaction
The UBX domain has a ubiquitin-like structure [38] and
is widely used by p97 co-factors to interact with p97 N-
termini [13]. Our analysis confirms that the UBX
domain is the only domain of UBXN7 required for p97
binding.
Both UBA and UIM have been characterized exten-
sively as ubiquitin-binding modules [39]. NEDD8 and
ubiquitin sequences are 57% identical resulting in a very
similar three-dimensional fold, termed the ubiquitin
superfold. Most importantly, the hydrophobic surface of
ubiquitin (formed by Leu8, Ile44, His68 and Val70) that
interacts with ubiquitin-binding domains such as UBA
[40] and UIM [41] is conserved in NEDD8 [42]. UBA
and UIM interact with NEDD8 in vitro [43,44] and also
with another domain from the ubiquitin superfold
f a m i l y ,t h eU B Ld o m a i n[ 4 5 ] .I np r i n c i p l e ,e i t h e rU B A
or UIM could serve as a docking site for neddylated-
cullins.
We show that within UBXN7, UBA and UIM play dis-
tinct roles. In cell extracts, the UBXN7 mutant lacking
the UBA domain is fully competent in interacting with
cullins, thus ruling out the involvement of this domain
in cullin-binding. This mutant is the least competent in
ubiquitin-binding, but it is not fully defective. It is possi-
ble that, in this case, ubiquitin-binding is not direct, but
mediated by the UIM motif bound to cullins. In con-
trast, UBXN7 lacking the UIM motif or carrying point
mutations therein is strongly defective in cullin-binding.
The residual CUL2-binding observed for the ΔUIM
mutant may be mediated by its UBA-dependent interac-
tion with ubiquitylated substrates of CRL2. Indeed this
mutant retains the ability to interact with HIF1a carry-
ing long ubiquitin-chains. We argue that the UIM motif
contributes to the direct binding of UBXN7 to neddy-
lated-cullins. This conclusion is strongly supported by
our in vitro binding assays where a UBXN7 variant lack-
ing the UIM motif becomes defective in binding to
NEDD8- but not ubiquitin-agarose. This experiment
also clarifies that the UIM motif recognizes the NEDD8
modification per se rather than the neddylated confor-
mation of cullins.
The data presented here suggest that each of the three
domains found in UBXN7 enables a specific interaction
to occur. Thus, the UIM motif allows docking of
UBXN7 on neddylated-cullins, the UBA domain is
required for binding ubiquitylated-protein substrates,
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Figure 6 HIF1a carrying long ubiquitin-chains becomes promiscuous in its interaction with ubiquitin-receptors.( A) FAF1 interacts, albeit
inefficiently, with HIF1a carrying long ubiquitin-chains (top panel). Flag-UBXN7 or Flag-FAF1 was immunoprecipitated from HeLa cells treated
with 10 μM MG132, 1 μM MLN4924, or a combination of the two for two hours. (B) Flag-UBXN7 (green) localizes to the nucleus of HeLa cells.
The DNA was stained with DAPI (blue). The scale bar represents 15 μm. (C) RAD23B interacts with slower-migrating, poly-ubiquitylated HIF1a
(top panel). Flag-UBXN7 or Flag-RAD23B was immunoprecipitated from HeLa cells using anti-Flag beads. The indicated proteins were detected
by western blotting using specific antibodies.
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Page 10 of 15and the UBX domain recruits the p97 complex (Figure
7). Future work will reveal the role played by the UAS
domain.
Processivity versus selectivity in CRL-dependent
degradation
Having established that UBXN7 can directly interact
with neddylated CRL complexes, a key question is
whether this interaction might have any effect on the
ubiquitin-ligase activity of CRLs.
The data presented here lead us to speculate that
UBXN7 is not only a ubiquitin-binding adaptor for p97,
but it may also embody a novel mechanism of CRL inhi-
bition. This would be in agreement with our previous
observation that UBXN7 depletion by siRNA causes a
r e d u c t i o ni nH I F 1 a levels and not HIF1a accumulation
as would be expected were it simply mediating HIF1a
interaction with p97 [15].
Our finding that UBXN7 over-expression causes the
accumulation of HIF1a mostly in its non-ubiquitylated
form suggests that the UIM-NEDD8 interaction would
have a negative effect on ubiquitin-chain elongation,
that is, reduce the processivity of the CRL ubiquitin-
ligase. UBXN7 over-expression causes not only HIF1a
accumulation, but also converts CUL2 to its neddylated
form. Because both effects are entirely dependent on the
UIM motif, it is tempting to propose that by sequester-
ing CUL2 in its neddylated form, UBXN7 might steri-
cally hinder the transition of the CRL complex to an
open conformation and thereby mitigate the positive
effect NEDD8 has on CRL E3 activity.
We find that ubiquitin-receptor selectivity is compro-
mised when HIF1a carries long ubiquitin-chains. Hence,
we suggest that reduced CRL processivity would favor
p97 recruitment to the UBX-domain of UBXN7 rather
than recruitment of alternative ubiquitin-receptors to a
fast-growing ubiquitin chain. Through its prior docking
on the neddylated-CRL, UBXN7 would be ideally poised
to modulate substrate-ubiquitylation and to shift the
balance towards p97 recruitment.
UBXN7 recruits p97 to nuclear HIF1a
Employing p97 complexes as the ubiquitin-receptor of
choice is particularly important in the nucleus, where
HIF1a forms complexes with HIF1b and associates with
the promoters of its target genes [46-48]. Among the
various ubiquitin-receptors, p97 uniquely provides the
segregase activity required to release nuclear HIF1a
from its protein partners and/or from chromatin prior
to its degradation. Endogenous HIF1a is found in the
nuclei of normoxic cells from normal and tumor tissues
[49-51] and poly-ubiquitylated HIF1a is detected exclu-
sively in the nuclei of normoxic HeLa cells [52]. Consis-
tent with the notion that UBXN7/p97 targets specifically
nuclear HIF1a, we find that Flag-UBXN7 localizes to
the nucleus of normoxic HeLa cells.
Conclusions
Herein we show that among the ubiquitin-binding adap-
tors of p97, UBXN7 has the unique ability to directly
dock onto neddylated cullins. This function depends on
the UIM motif that is only found in the UBXN7 co-fac-
tor of p97. Furthermore, UBXN7 interaction with ned-
dylated CUL2 appears to negatively affect its ubiquitin-
ligase activity as UBXN7 over-expression causes the
accumulation of non-ubiquitylated HIF1a in a UIM-
dependent manner.
It has been puzzling why p97 has such a multitude of
ubiquitin-binding co-factors, for example, NPL4, UFD1,
various UBA-UBX proteins, PLAA. Our data indicate
that the role of UBXN7 as a substrate-binding adaptor
for p97 is secondary to its ability to interact with CRLs
CUL2
EloC
EloB RBX1 N
E
D
D
8
UBA UBX
UIM
HIF1α-Ubi p97/NPL4/UFD1
UBXN7
Figure 7 UBXN7 docks on neddylated cullins using its UIM motif. Each domain in UBXN7 mediates a specific interaction: the UBA domain
interacts with ubiquitylated HIF1a, the UIM motif anchors the neddylated CRL complex and the UBX domain recruits the p97/NPL4/UFD1
complex.
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tion with cullins does not require p97, while UBXN7
interaction with NPL4/UFD1 is mediated by p97 [15],
suggesting that UBXN7 acts upstream of NPL4/UFD1 in
the p97 pathway of ubiquitin-dependent degradation. It
is feasible to assume that various adaptors of p97 func-
tion in a sort of relay and their temporal succession is
dictated by functions other than mere ubiquitin recogni-
tion. Future work will tell for how many of the above
proteins their ubiquitin-binding capacity is just one
facet of a more complex function.
Methods
Cloning Information
Human UBXN7 [GenBank: NM_015562] was amplified
from EST IMAGE 5294894. For mammalian expression,
wild-type and mutant UBXN7 variants were subcloned
as BamH1/Not1 inserts into pCMV5-Flag. For bacteria
expression, UBXN7 variants were subcloned into a mod-
ified pGEX6P-1 vector containing a TEV protease site
and a Flag tag downstream of the GST. Human CUL2
[GenBank: NM_003591] and RAD23B [GenBank:
NM_002874.3] were amplified from EST IMAGE
4104375 and 3906269, respectively, for subcloning into
pCMV5-Flag as BamH1/Not1 inserts. Human FAF1
[GenBank: NM_007051.2] and PSMD4 [GenBank:
NM_002810.2] were amplified from EST IMAGE
5928559 and 6285035, respectively, for subcloning into
pCMV5-Flag as Sal1/Not1 inserts. To construct the
baculovirus vector for dual expression of GST-CUL2
and HIS6-RBX1, human CUL2 was subcloned as a
BamH1/Not1 insert into the PPH driven cassette of
pFastBac-Dual-GST. RBX1 [GenBank: NM_014248.2]
was amplified from EST IMAGE 3138751 adding an
Nhe1 site and 6HIS tag on the 5’ primer and a Kpn1
site on the 3’ primer and subcloned into the PP10 driven
cassette of pFastBac-Dual-GST-CUL2.
PCR reactions were carried out using KOD Hot Start
DNA Polymerase (Merck Millipore, Darmstadt, Ger-
many). All full-length PCR products were cloned into
pSc-B (Agilent Technologies, Santa Clara, CA, USA)
and fully sequenced prior to further subcloning. All
mutations and deletions were made following the
Quickchange method (Agilent Technologies), but using
KOD Hot Start DNA Polymerase. DNA sequencing was
performed by the Sequencing Service at the College of
Life Sciences (CLS), University of Dundee.
Cell Extracts and Immunoprecipitation
For immunoprecipitation experiments, the cells were
lysed in buffer A (50 mM N-2-hydroxyethylpiperazine-
N’-2-ethanesulfonic acid (HEPES)/KOH, pH 7.2; 5 mM
Mg(OAc)2; 70 mM KOAc; 0.2% Triton X-100; 10% gly-
cerol; 0.2 mM ethylenediaminetetraacetic acid (EDTA);
protease inhibitors) and incubated with anti-UBXN7
antibodies crosslinked to Protein A-agarose or anti-Flag
beads (Sigma, Saint Louis, MO, USA). For the experi-
ment in Figure 5D, PhosSTOP phosphatase inhibitor
(Roche. Mannheim, Germany) was also added to the
lysis buffer.
Total extracts were prepared using buffer B (50 mM
HEPES/KOH, pH 7.2; 400 mM NaCl; 1% NP-40; 0.2
mM EDTA; 10% glycerol; protease inhibitors) to facili-
tate extraction of nuclear HIF1a.
Antibodies and Chemicals
The following antibodies were used for protein detection
by western blotting: mouse anti-Flag M2 (Sigma), mouse
anti-ubiquitin FK2 (Enzo, Farmingdale, NY, USA),
mouse anti-p97 (Fitzgerald, North Acton, MA, USA),
mouse anti-CUL3, mouse anti-elongin C (BD Transduc-
tion Laboratories, San Jose, CA, USA), rabbit anti-
CUL4A (Cell Signalling, Danvers, MA, USA), rabbit and
mouse anti-CUL1, rabbit anti-CUL2, rabbit anti-NEDD8
(Invitrogen, Camarillo, CA, USA), rabbit anti-RBX1
(Thermo, Fremont, CA, USA), rabbit anti-VHL (Santa
Cruz Biotechnology, Santa Cruz, CA, USA), rabbit anti-
HIF1a (Novus, Littleton, CO, USA), rabbit anti-UBXN7
(courtesy of Millipore, Billerica, MA, USA). MG132
(Enzo) was added at 10 μM to the tissue culture media
for two hours prior to cell lysis. The Division of Signal
Transduction Therapy (DSTT) at the CLS, University of
Dundee synthesized MLN4924, as described previously
[53]. The cells were incubated with 1 μM MLN4924 for
two hours.
Recombinant Protein Expression and Purification
The Protein Production and Assay Development Team
(PPADT) at SCILLS produced the various recombinant
proteins in bacteria, as follows. Expression vectors for
full length, UBA- or UIM-deleted UBXN7 were trans-
formed into BL21 DE3 cells. Overnight cultures were
grown in LB medium (1% tryptone, 0.5% yeast extract,
1% NaCl) supplemented with carbenicillin. Autoinduc-
tion medium was inoculated and the cells were left to
grow at 37°C until the OD600 reached about 1.5. The
temperature was then dropped to 15°C and the cells
were left for about 16 hours to express the protein. The
cells were collected by centrifugation and resuspended
in 50 mM Tris-HCl pH 7.5, 250 mM NaCl, 0.4% Triton
X-100, 0.1 mM EDTA, 0.1 mM ethylene glycol tetraace-
tic acid (EGTA), 1 mM dithiothreitol (DTT) and pro-
tease inhibitors. The suspension was sonicated and the
insoluble material was sedimented by centrifugation at
4°C, 28,000 g for 20 minutes. The supernatant was incu-
bated with GSH-sepharose for one hour. The sepharose
was washed four times and UBXN7 was recovered upon
cleavage with TEV protease. The proteins were further
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Page 12 of 15purified by chromatography over a Superdex 75 column
after which protein purity exceeded 90%.
The vector expressing Flag-CUL1(324-776)/GST-HA-
RBX1 [33] was also transformed into BL21 cells, but
grown in LB/ampicillin and induced with 0.1 mM iso-
propyl-beta-D-thiogalactopyranoside (IPTG) at an
OD600 of 0.7. This was then left to express at 15°C over-
night and the lysate was prepared as described above.
The dual expression vector encoding GST-CUL2/
HIS6-RBX1 was used to generate recombinant baculo-
viruses using the Bac-to-Bac system (Invitrogen) follow-
ing the manufacturer’s protocol. These baculoviruses
were used to infect Spodoptera frugiperda 21 cells (1.5 ×
10
6/ml) at a multiplicity of infection of 5 and the
infected cells were harvested 48 hours post-infection.
GST-CUL2/RBX1 was purified on GSH-Sepharose and
dialysed into 50 mM Tris-HCl pH 7.5, 0.1 mM EGTA,
150 mM NaCl, 270 mM sucrose, 0.03% Brij-35, 0.1% 2-
mercaptoethanol, 1 mM benzamidine, 0.1 mM phenyl-
methylsulfonyl fluoride (PMSF).
In Vitro Binding Assays
The Flag-CUL1(324-776)/GST-HA-RBX1 complex was
immobilized on GSH-sepharose (GE). For each binding
assay, 10 μl beads carrying approximately 1 μgC U L 1 /
RBX1 were incubated for 30 minutes at 30°C with a
neddylation reaction mix containing NEDD8 E1
(PPADT, SCILLS), NEDD8 E2 (Ubiquigent, Dundee,
UK), NEDD8 and ERS (BostonBiochem, Cambridge,
MA, USA) in buffer C (50 mM HEPES/KOH, pH 7.5;
60 mM KOAc; 5 mM MgCl2; 5% glycerol, 1 mM DTT).
Mock neddylation reactions were performed in parallel
by omitting NEDD8 from the mixture. The beads were
then washed and incubated for one hour with 3 μgo f
wild-type or mutant Flag-UBXN7 in buffer C without
DTT and supplemented with 0.1% Triton X-100 (buffer
D). After washing the beads, the bound proteins were
eluted with Laemmli buffer. The binding assays were
also performed using naked beads to account for non-
specific UBXN7 binding to the beads.
GST was cleaved off CUL2 with PreScission protease
and the resulting CUL2/RBX1 was neddylated as above.
CUL2/RBX1 (1.5 μg) was pre-incubated with 1.5 μg
Flag-UBXN7 (approximately 1.5 times molar excess to
CUL2) for 30 minutes, followed by one hour incubation
with 10 μl anti-Flag beads in buffer D. The proteins
bound to beads were eluted by boiling in Laemmli
buffer.
Wild-type or mutant UBXN7 (25 μg) was incubated
for one hour with 10 μl NEDD8- or ubiquitin-agarose
(BostonBiochem) in buffer D and the bound proteins
were eluted as above.
Immunofluorescence Staining and Microscopy
For Flag-UBXN7 immunostaining, cells were grown on
coverslips and fixed with ice-cold methanol for six min-
utes at -20°C. Cells were then blocked in 1% BSA/PBS
for 30 minutes and subsequently incubated with mouse
anti-Flag M2 (Sigma) antibodies in 3% BSA/PBS, for
one hour at room temperature. After washing with PBS,
cells were incubated with donkey anti-mouse FITC-con-
jugated antibodies (Jackson ImmunoResearch, West
Grove, PA, USA) for 45 minutes. The cell nuclei were
stained with 4’,6-diamidino-2-phenylindole (DAPI, Invi-
trogen). The coverslips were mounted onto glass slides
using hydromount (National Diagnostics, Atlanta, GA,
USA).
Images were obtained with a DeltaVision Spectris
microscope (Applied Precision), using a CoolSNAP HQ
camera (Roper) and a 60 × 1.4 NA objective (Olympus).
The SoftWorx software (Applied Precision) was used for
acquisition and deconvolution.
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